Search Results 551-560 of 17221 for semaglutide interactions

  1. Neurology - Clinical trials - Mayo Clinic

    ... interaction of local hippocampal and neocortical networks with distributed brain activity. A Study to Develop A Family Registry to Collect Alzheimer's ...

  2. Food allergy vs. food intolerance: What's the difference? - Mayo Clinic

    If you have a food allergy, you may be at risk of a life-threatening allergic reaction (anaphylaxis) — even if past reactions have been mild. Learn how to ...

  3. Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia - Mayo Clinic

    Bortezomib and sorafenib tosylate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy work in ...

  4. Integrative medicine - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  5. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  6. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis - Mayo Clinic

    About this study. The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the ...

  7. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

    Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan ...

  8. An Expanded Access Study Of Sofosbuvir Combined With Ribavirin And Either With Or Without Pegylated Interferon For Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    ... interaction risk to the subject; Unable or unwilling to follow the contraception requirements. Participating Mayo Clinic locations. Study statuses change often ...

  9. Tumors And Masses Clinical Trials - Mayo Clinic Research

    ... interactions. Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Scottsdale/Phoenix, AZ. This is a Phase 1, open ...

  10. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

    Also, bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as elotuzumab, can block ...